Novartis raises outlook

Note: This section contains information in English only.

Fri, 18 Jul 2025 21:30:04 GMT

Source: Dukascopy Bank SA

Novartis raised its 2025 outlook, now expecting core profit to grow in the low teens, boosted by strong Q2 sales of key drugs like breast cancer treatment Kisqali.

Back to articles

Actual Topics

21 Jul 2025

Chevron to proceed with turnaround plan

Chevron can move ahead with its $53B Hess deal after beating Exxon in court, giving it access to a major oil find and boosting CEO Mike Wirth's turnaround plan.

18 Jul 2025

Walmart sees profit decline in Mexico

Walmart Mexico Q2 profit dropped 10%, missing forecasts, as weak consumer spending slowed recovery, despite an 8% rise in sales.

18 Jul 2025

Japan and U.S. engage in trade dialog

Japan, U.S. held 45-min call on tariffs; reaffirmed positions and vowed to continue dialogue, Japan's government said Thursday.

Novartis raises outlook

Telefon

Actual Topics

Chevron to proceed with turnaround plan

Walmart sees profit decline in Mexico

Japan and U.S. engage in trade dialog